Why is Syncom Formul. falling/rising?

As of 29-Sep, Syncom Formulations (India) Ltd is experiencing a decline in its stock price, currently at 16.30, which reflects a decrease of 0.41 or 2.45%. The stock has underperformed its sector by 2.59% today and has been on a consecutive downward trend for the last seven days, resulting in a total decline of 9.8% during this period. Over the past week, the stock has fallen by 7.18%, while the Sensex has only decreased by 2.18%. Despite declaring positive results for the last five consecutive quarters, with significant growth in PAT and net sales, the company faces challenges with poor long-term growth rates and a high valuation compared to its peers, contributing to the recent price drop.
In the broader market context, Syncom Formulations has underperformed significantly over the past year, with a return of -25.84% compared to the BSE500's decline of only -7.50%. This stark contrast indicates a lack of investor confidence, as evidenced by the negligible stake held by domestic mutual funds, which may reflect their discomfort with the stock's current price. Additionally, the stock is trading below all its moving averages, further signaling bearish sentiment among investors. Overall, the combination of short-term underperformance, long-term growth concerns, and high valuation relative to peers has led to the stock's recent decline.